Clincosm LogoSign in Get a demo

Treatment of Acetabular Fracture: the Contribution of the 3D Impression

Sponsor
Groupe Hospitalier Paris Saint Joseph (Other)
Overall Status
Completed
CT.gov ID
NCT03312491
Collaborator
(none)
30
Enrollment
1
Location
4.3
Actual Duration (Months)
7
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Acetabular fracture are common in elder patients and high energy trauma in younger one.

However, the fracture deplacement induces incongruity between cotyloid cavity and femoral head. Anatomic reduction and osteosynthesis of these fracture are technically difficult .

3D printing ease the process of operating planification or implant fabrication. The 3D impression allows to obtain a model on the scale of the pond of the patient allowing to pre mold plates on the anatomy of the patient before he is operated with the aim of decreasing the surgical time and improving the quality of the reduction.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    30 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Treatment of Acetabular Fracture: the Contribution of the 3D Impression
    Actual Study Start Date :
    Aug 22, 2016
    Actual Primary Completion Date :
    Dec 31, 2016
    Actual Study Completion Date :
    Dec 31, 2016

    Outcome Measures

    Primary Outcome Measures

    1. operating room time [day1]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion Criteria:

    • age >18

    • acetabulum fracture within one month

    • anterior access or double access

    Exclusion Criteria:
    • acetabulum fracture more than one month

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Groupe Hospitalier Paris Saint Joseph Paris Ile-de-France France 75014

    Sponsors and Collaborators

    • Groupe Hospitalier Paris Saint Joseph

    Investigators

    • Study Chair: Pomme JOUFFROY, MD, GHPSJ

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Groupe Hospitalier Paris Saint Joseph
    ClinicalTrials.gov Identifier:
    NCT03312491
    Other Study ID Numbers:
    • 3D COTYLE
    First Posted:
    Oct 17, 2017
    Last Update Posted:
    Oct 17, 2017
    Last Verified:
    Oct 1, 2017
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Fractures, Bone

    Study Results

    No Results Posted as of Oct 17, 2017